A case of tardive dystonia associated with long-acting injectable paliperidone palmitate

Eur Neuropsychopharmacol. 2016 Jul;26(7):1251-2. doi: 10.1016/j.euroneuro.2016.04.006. Epub 2016 Apr 26.
No abstract available

Keywords: Clozapine; Paliperidone palmitate; Speech therapy; Tardive dystonia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Combined Modality Therapy
  • Deglutition Disorders / etiology
  • Deglutition Disorders / prevention & control
  • Delayed-Action Preparations / administration & dosage
  • Delayed-Action Preparations / adverse effects
  • Dopamine D2 Receptor Antagonists / administration & dosage
  • Dopamine D2 Receptor Antagonists / adverse effects*
  • Drug Monitoring
  • Dysarthria / etiology
  • Dysarthria / prevention & control
  • Female
  • Humans
  • Neurotoxicity Syndromes / etiology*
  • Neurotoxicity Syndromes / therapy
  • Obsessive Behavior / chemically induced
  • Obsessive Behavior / prevention & control
  • Paliperidone Palmitate / administration & dosage
  • Paliperidone Palmitate / adverse effects*
  • Speech Therapy
  • Tardive Dyskinesia / chemically induced*
  • Tardive Dyskinesia / therapy
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Delayed-Action Preparations
  • Dopamine D2 Receptor Antagonists
  • Paliperidone Palmitate